Calcium inhibition of cardiac adenylyl cyclase. Evidence for two distinct sites of inhibition
- PMID: 2015619
- DOI: 10.1016/0143-4160(91)90081-o
Calcium inhibition of cardiac adenylyl cyclase. Evidence for two distinct sites of inhibition
Abstract
Increasing the free calcium concentration from 10(-8) M to 10(-4) M inhibited cardiac sarcolemmal adenylyl cyclase activated by the addition of 5 X 10(-4) M forskolin or 1 X 10(-4) M GTP or Gpp(NH)p. The calcium inhibition curve in the presence of all three activators was shallow and best fit by a two site model of high affinity (less than 1.0 microM) and low affinity (greater than 0.1 mM). Gpp(NH)p appeared to decrease the sensitivity of adenylyl cyclase to inhibition by calcium at the high affinity site. Similar inhibition constants were obtained with each of the activators. Calmodulin content of native freeze-thaw vesicles was 76.2 +/- 14.2 ng/mg. Treatment of the vesicles with 1 mM EGTA to remove calmodulin significantly reduced calmodulin content to 19.7 +/- 1.35 ng/mg. This treatment had no significant effect on the calcium inhibition profile. Increasing free calcium to 3 X 10(-6) M was shown to have no effect on the EC50 estimated for either Gpp(NH)p or forskolin but did slightly increase the EC50 estimated for Mg2+ in the presence of maximal concentrations of either activator. Nevertheless, maximally stimulating concentrations of Mg2+ were unable to overcome calcium inhibition. Pretreatment of sarcolemmal membranes with pertussis toxin was shown to have no significant effect on calcium inhibition of adenylyl cyclase. The results suggest that the overall inhibitory action of calcium was most likely calmodulin independent and involved a direct interaction with the catalytic subunit at two distinct sites of high and low affinity. At the low affinity site calcium most likely competes with Mg2+ for an allosteric divalent cation binding site.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Stable GDP analog-induced inactivation of G(i) proteins promotes cardiac adenylyl cyclase inhibition by guanosine 5'-(beta gamma-imino)triphosphate and muscarinic acetylcholine receptor.Biochim Biophys Acta. 1996 Jun 13;1282(1):11-6. doi: 10.1016/0005-2736(96)00029-6. Biochim Biophys Acta. 1996. PMID: 8679647
-
Prostaglandin E2 receptors in the heart are coupled to inhibition of adenylyl cyclase via a pertussis toxin sensitive G protein.Can J Physiol Pharmacol. 1992 Jan;70(1):77-84. doi: 10.1139/y92-011. Can J Physiol Pharmacol. 1992. PMID: 1316218
-
Muscarinic receptor regulation of cardiac adenylate cyclase activity.J Mol Cell Cardiol. 1987 Jan;19(1):47-61. doi: 10.1016/s0022-2828(87)80544-8. J Mol Cell Cardiol. 1987. PMID: 3560238
-
The structure, catalytic mechanism and regulation of adenylyl cyclase.Curr Opin Struct Biol. 1998 Dec;8(6):713-9. doi: 10.1016/s0959-440x(98)80090-0. Curr Opin Struct Biol. 1998. PMID: 9914249 Review.
-
Isoform-specific regulation of adenylyl cyclase: a potential target in future pharmacotherapy.Expert Opin Ther Targets. 2003 Jun;7(3):441-51. doi: 10.1517/14728222.7.3.441. Expert Opin Ther Targets. 2003. PMID: 12783579 Review.
Cited by
-
Alterations of cardiac beta-adrenoceptor mechanisms due to calcium depletion and repletion.Mol Cell Biochem. 2002 Mar;232(1-2):63-73. doi: 10.1023/a:1014845300488. Mol Cell Biochem. 2002. PMID: 12030381
-
Single cell Ca2+/cAMP cross-talk monitored by simultaneous Ca2+/cAMP fluorescence ratio imaging.Proc Natl Acad Sci U S A. 1996 May 14;93(10):4577-82. doi: 10.1073/pnas.93.10.4577. Proc Natl Acad Sci U S A. 1996. PMID: 8643446 Free PMC article.
-
Cloning and expression of a Ca(2+)-inhibitable adenylyl cyclase from NCB-20 cells.Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6716-20. doi: 10.1073/pnas.89.15.6716. Proc Natl Acad Sci U S A. 1992. PMID: 1379717 Free PMC article.
-
Ca(2+)-stimulated adenylyl cyclases regulate the L-type Ca(2+) current in guinea-pig atrial myocytes.J Physiol. 2012 Apr 15;590(8):1881-93. doi: 10.1113/jphysiol.2011.227066. Epub 2012 Feb 20. J Physiol. 2012. PMID: 22351635 Free PMC article.
-
Ca(2+)-dependent and -independent mechanism of cyclic-AMP reduction: mediation by bradykinin B2 receptors.Br J Pharmacol. 1995 Jul;115(6):937-44. doi: 10.1111/j.1476-5381.1995.tb15901.x. Br J Pharmacol. 1995. PMID: 7582524 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources